SEARCH
Quotes News NAV
Balance Sheet Markets  >  Corporate Information  >   Balance Sheet
Glaxosmithkline Pharmaceuticals Ltd Industry:  Pharmaceuticals - Multinational
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500660 INE159A01016 91.3566062 GLAXO 1.6 33,840.55 53.24 37.52 10
      ParticularsMar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
Mar 2018
(Rs.Cr)
SOURCES OF FUNDS :      
Share Capital 169.41169.41169.41169.41169.4184.70
Reserves Total 1583.592508.211327.711670.631973.011995.25
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1753.002677.621497.121840.042142.422079.95
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 15.5420.0834.630.180.580.99
Total Debt15.5420.0834.630.180.580.99
Other Liabilities254.22263.00260.29289.39315.72288.44
Total Liabilities2022.762960.701792.042129.612458.722369.38
APPLICATION OF FUNDS :      
Gross Block 635.93593.89602.891454.59561.30408.14
Less : Accumulated Depreciation 305.99263.26216.00696.53129.6983.57
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 329.94330.63386.89758.06431.61324.57
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress20.3130.5013.21120.121002.64922.90
Producing Properties0.000.000.000.000.000.00
Investments 542.78390.0924.4924.4924.5547.67
Current Assets, Loans & Advances      
Inventories 437.70512.71523.34483.03486.49500.18
Sundry Debtors 192.38205.24215.6099.80120.49146.96
Cash and Bank Balance1150.732479.111157.681066.411155.331279.69
Loans and Advances 167.62108.05274.71107.54228.87236.21
Total Current Assets1948.433305.122171.331756.781991.182163.05
Less : Current Liabilities and Provisions      
Current Liabilities 590.941046.53866.70559.871205.151344.46
Provisions 713.99615.36438.35442.04245.32251.18
Total Current Liabilities & Provisions1304.941661.901305.051001.921450.471595.64
Net Current Assets643.491643.22866.28754.86540.71567.41
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets151.38131.67117.24126.0984.60119.26
Deferred Tax Liability18.2018.8915.5717.2424.1216.20
Net Deferred Tax133.18112.78101.67108.8560.48103.06
Other Assets353.06453.48399.49363.22398.72403.78
Total Assets2022.762960.701792.032129.602458.712369.39
Contingent Liabilities350.59351.10485.78471.42512.80637.85